Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 1
1999 2
2000 5
2001 1
2002 4
2003 4
2004 3
2005 8
2006 5
2007 7
2008 11
2009 9
2010 14
2011 14
2012 18
2013 36
2014 23
2015 19
2016 13
2017 10
2018 13
2019 22
2020 9
2021 12
2022 7
2023 5
2024 11
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Results by year

Filters applied: . Clear all
Page 1
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.
Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P. Aerts HJ, et al. Among authors: bussink j. Nat Commun. 2014 Jun 3;5:4006. doi: 10.1038/ncomms5006. Nat Commun. 2014. PMID: 24892406 Free PMC article.
Biology of hypoxia.
Span PN, Bussink J. Span PN, et al. Among authors: bussink j. Semin Nucl Med. 2015 Mar;45(2):101-9. doi: 10.1053/j.semnuclmed.2014.10.002. Semin Nucl Med. 2015. PMID: 25704383 Review.
Molecular imaging of hypoxia.
Oyen WJ, Kaanders JH, Bussink J. Oyen WJ, et al. Among authors: bussink j. Q J Nucl Med Mol Imaging. 2013 Sep;57(3):217-8. Q J Nucl Med Mol Imaging. 2013. PMID: 24045618 No abstract available.
[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription.
Kaanders JHAM, Bussink J, Aarntzen EHJG, Braam P, Rütten H, van der Maazen RWM, Verheij M, van den Bosch S. Kaanders JHAM, et al. Among authors: bussink j. Semin Radiat Oncol. 2023 Jul;33(3):287-297. doi: 10.1016/j.semradonc.2023.03.006. Semin Radiat Oncol. 2023. PMID: 37331783 Free article. Review.
Longitudinal Image Data for Outcome Modeling.
van Timmeren JE, Bussink J, Koopmans P, Smeenk RJ, Monshouwer R. van Timmeren JE, et al. Among authors: bussink j. Clin Oncol (R Coll Radiol). 2025 Feb;38:103610. doi: 10.1016/j.clon.2024.06.053. Epub 2024 Jun 27. Clin Oncol (R Coll Radiol). 2025. PMID: 39003124 Free article. Review.
Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma.
Kleinendorst SC, Oosterwijk E, Molkenboer-Kuenen J, Frielink C, Franssen GM, Boreel DF, Tamborino G, Gloudemans M, Hendrikx M, Kroon D, Hillen J, Bussink J, Muselaers S, Mulders P, Konijnenberg MW, Wheatcroft MP, Twumasi-Boateng K, Heskamp S. Kleinendorst SC, et al. Among authors: bussink j. Theranostics. 2024 Jun 11;14(9):3693-3707. doi: 10.7150/thno.96944. eCollection 2024. Theranostics. 2024. PMID: 38948062 Free PMC article.
Improving chemoradiation efficacy by PI3-K/AKT inhibition.
Stegeman H, Span PN, Kaanders JH, Bussink J. Stegeman H, et al. Among authors: bussink j. Cancer Treat Rev. 2014 Dec;40(10):1182-91. doi: 10.1016/j.ctrv.2014.09.005. Epub 2014 Oct 5. Cancer Treat Rev. 2014. PMID: 25312653 Review.
257 results